ToxSci Advance Access published online on June 30, 2008
Toxicological Sciences, doi:10.1093/toxsci/kfn126
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Evaluation of the embryotoxic potency of compounds in a newly revised high throughput embryonic stem cell test
Address: Johnson & Johnson Pharmaceutical Research & Development (J&J-PRD), Department of Mechanistic Toxicology, Turnhoutseweg 30, Beerse, B-2340, Belgium, Telephone 0032-14608329, Fax 0032-14605150
* Corresponding author; e-mail APeters5{at}prdbe.jnj.com (+32-14608329)
Received April 18, 2008; revision received June 17, 2008; accepted June 19, 2008
 |
Abstract |
|---|
The ability of murine-derived embryonic stem cells (D3) to differentiate into cardiomyocytes is the basis of the embryonic stem cell test (EST). With the EST, chemicals and pharmaceuticals can be assessed for their embryotoxic potency early on in the development process. In order to come to a higher throughput EST, a 96-well based method was developed based on low attachment well plates that allow for the formation of embryonic bodies from which the stem cells can differentiate. Twelve test compounds were selected based on their reported in vitro and in vivo embryotoxic potency. In the 96-well based EST, reportedly strong embryotoxic compounds 5-Fluorouracil, 6-Aminonicotinamide (6-AN), Methylmercury chloride, and Hydroxyurea were correctly ranked with corresponding Relative Embryotoxicity Potency values (REP, based on the EC50 (µM) value of 6-AN) of 2.6±2.9, 1, 2.0±3.1, and 0.07±0.05, respectively. Moderately embryotoxic compounds Valproic acid, Boric acid, Methoxyacetic acid, and Lithium chloride resulted in a correct ranking with REP values of 0.01±0.003, 0.001±0.001, 0.0007±0.001, and 0.0006±0.0004, respectively. The included non-embryotoxic compounds Penicillin G, Acrylamide, and Saccharin did not result in an inhibition of D3 cells to differentiate into cardiomyocytes, other than related to cytotoxicity (REP value of 0.00001). However, Diphenhydramine resulted in an inhibitory effect similarly to the strong embryotoxic compound Hydroxyurea, with a REP value of 0.40±0.36. However, further evaluation suggested this was due to direct inhibition of the contractile capacity of the D3 cardiomyocytes, rather than an embryotoxic mechanism. The 96-well based EST is a promising addition to the screening process of newly developed chemicals and pharmaceuticals.
Key Words: embryonic stem cells; D3; EST; Relative Embryotoxic Potency; REP.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  R. E. Chapin and D. B. Stedman Endless Possibilities: Stem Cells and the Vision for Toxicology Testing in the 21st Century Toxicol. Sci., November 1, 2009; 112(1): 17 - 22. [Abstract] [Full Text] [PDF]
|
|